NCT06208813 Creatine Supplementation in Concussion Recovery
| NCT ID | NCT06208813 |
| Status | Recruiting |
| Phase | — |
| Sponsor | San Diego State University |
| Condition | Concussion, Brain |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-02-01 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The proposed study aims to compare concussion recovery in those supplementing creatine and those not supplementing creatine. Specific aim 1: To compare number of days until asymptomatic between those taking creatine vs. those not taking creatine following a concussion. Hypothesis: The investigators hypothesize that individuals taking creatine will become asymptomatic sooner than those not taking creatine.Specific aim 2: To compare typical concussion assessment scores (i.e., symptom score, mental status, neurocognition, balance, motor coordination, and visual performance) between those taking creatine vs those not taking creatine following a concussion once asymptomatic.Hypothesis: The investigators hypothesize that individuals taking creatine will have better symptom scores, balance, mental status, and neurocognition assessment scores than those not taking creatine once asymptomatic. The investigators will calculate descriptive statistics for all demographic, days to asymptomatic, and concussion assessments. For specific aim 1, The investigators will calculate a t-test to determine if days to asymptomatic differed in those taking creatine vs. those not taking creatine. For specific aim 2, the investigators will calculate t-tests with Bonferonni corrections to determine if concussion assessment scores (Sport Concussion Office Assessment Tool-6 assessments, CNS Vital Signs, visual assessment) differed in those taking creatine vs. those not taking creatine.
Eligibility Criteria
Inclusion Criteria: * 18-35 years old with a diagnosed concussion within 72 hours post-injury Exclusion Criteria: * Learning disability, renal disease, mental behavior or migraine history, and current creatine use or have not taken creatine in the past 6 weeks
Contact & Investigator
Michelle Weber Rawlins
PRINCIPAL INVESTIGATOR
San Diego State University
Frequently Asked Questions
Who can join the NCT06208813 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Concussion, Brain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06208813 currently recruiting?
Yes, NCT06208813 is actively recruiting participants. Contact the research team at mrawlins@sdsu.edu for enrollment information.
Where is the NCT06208813 trial being conducted?
This trial is being conducted at San Diego, United States.
Who is sponsoring the NCT06208813 clinical trial?
NCT06208813 is sponsored by San Diego State University. The principal investigator is Michelle Weber Rawlins at San Diego State University. The trial plans to enroll 20 participants.